期刊文献+

壳聚糖-5-氟尿嘧啶微球的制备 被引量:6

Preparation of chitosan-5-fluorouracil microspheres
下载PDF
导出
摘要 为了制备靶向型药物载体系统,采用超声乳化技术,以5-氟尿嘧啶(5-Fu)为模型药物,液体石蜡为有机分散介质,Span 80为乳化剂,戊二醛为交联剂,对壳聚糖(CS)进行乳化交联,制备了壳聚糖-5-氟尿嘧啶(CS-5-Fu)微球.对超声频率为40 kHz时的制备条件进行了优化,优化条件为:戊二醛用量2 mL,CS浓度1.0%。5-Fu浓度1.0%.采用红外光谱和扫描电子显微镜等对该条件下所得产物的结构和形貌进行了表征,采用紫外-可见光谱对其药物释放性能进行了研究.研究结果表明,CS-5-Fu微球外形为比较规整的球形,粒径在1—4μm之间,分布均匀,包封率为46.7%.在pH=7.2的磷酸盐缓冲溶液中,CS-5-Fu微球在30h内的累积释药率为60.4%,具有明显的缓释作用. In order to prepare the targeting drug-loaded system, chitosan (CS) 5 - fluorouracil (5 -Fu)microspheres were prepared in emulsion by using ultrasonic treatment, glutaraldehyde as cross linking agent,span-80 as emulsifer and paraffin oil as oil phase. The condition of preparation has been optimized. The optimum conditions for preparation were as follows: ultrasonic frequency of 40 kHz, 2 mL glutaraldehyde, 1.0% chitosan and 1.0% 5 - fluorouracil. At these conditions, The CS -5 - Fu microspheres were characterized by IR, UV-Vis and SEM. The IR results indicate that 5 -Fu was loaded. SEM images show that the CS -5 -Fu microspheres are spherical shape with diameter' s range from 1 - 4 μm. The encapsulated capacity and drug releasing properties were investigated by UV-vis spectrum. The results indicate that the drug encapsulation efficiency of Chitosan (CS) 5- fluorouracil (5 -Fu) microspheres was 46.7%, and cumulative release percentage in the phosphate buffer (pH = 7.2) solutions was 60.4% in 30 h.
出处 《长沙理工大学学报(自然科学版)》 CAS 2006年第4期91-96,共6页 Journal of Changsha University of Science and Technology:Natural Science
基金 国家"863"计划资助项目(2001AA218011) 湖南省自然科学基金资助项目(06JJ20038)
关键词 壳聚糖 5-氟尿嘧啶 微球 制备 chitosan 5-fluorouracil microspheres preparation
  • 相关文献

参考文献17

  • 1[3]王振源.恶性肿瘤的化学治疗[M].哈尔滨:黑龙江科学技术出版社,1983.79-81.
  • 2何强芳,李国明,巫海珍,卢志敏,李良.5-氟尿嘧啶壳聚糖微球的制备及其释药性能[J].应用化学,2004,21(2):192-196. 被引量:48
  • 3[3]Gomez J A,Trujillo M A,Campos J,et al.Synthesis of novel 5-fluorouracil derivatives with 1,4-oxaheteroepane moieties[J].Tetrahedron,1998,(54):13295-13312.
  • 4[4]Potineni A,Lynn D,Langer R,et al.Poly(ethylene oxide)-modified poly(β-amino ester)nanoparticles as a pH-sensitive biodegradable system for paclitaxel delivery[ J ].Journal of Controlled Release,2003,(86):223-234.
  • 5[5]Pignatello R,Bucolo C,Spedalieri G,et al.Flurbiprofen-loaded acrylate polymer nanosuspensions for ophthalmic application[ J ].Biomaterials,2002,23 (15):3247-3255.
  • 6[6]Janes K A,Fresneau M P,Marazuela A,et al.Chitosan nanoparticles as delivery systems for doxorubicin[J].Journal of Controlled Release,2001,(73):255-267.
  • 7[7]Simeonova M,Velichkova R,Ivanova G,et al.Poly (butylcyanoacrylate) nanoparticles for topical delivery of 5-fluorouracil[J].International Journal of Pharmaceutics,2003,(263):133-140.
  • 8[8]Denkbas E B,Seytal M,Piskin E.Implantable 5-fluorouracil loaded chitosan scaffolds prepared by wet spinning[ J ].Journal of Membrane Science,2000,(172):33-38.
  • 9于波涛,张志荣,曾仁杰.肝靶向氟尿嘧啶类脂纳米粒的研究[J].药学学报,2000,35(9):700-705. 被引量:40
  • 10魏红,李永国,俞耀庭.纳米技术在生物医学工程领域的应用——研究现状和发展趋势[J].国外医学(生物医学工程分册),1999,22(6):340-344. 被引量:45

二级参考文献27

  • 1王美玲,韩金祥.大蒜与肿瘤[J].中国肿瘤,1994,3(6):6-8. 被引量:10
  • 2王亚敏,石庭森,蒲永林,朱建纲,赵延乐.顺铂壳聚糖微球的制备及特性研究[J].药学学报,1996,31(4):300-305. 被引量:24
  • 3关丽 李国明 黄晓燕.J South China Normal Unv(Nat SciEdn)(华南师范大学学报(自然科学版))[J],2001,2(1):79-79.
  • 4王亚敏 石庭森 蒲永林.Acta Pharm Sin(药学学报)[J],1996,31(4):300-300.
  • 5Sakane T,Yamashita S,Yata H,et al.Transnasal delivery of 5-fluorouracil to the brain in the rat[J].J Drug Targeting,1999,7(3):233-239.
  • 6Lim ST,Mrtin GP,Berry DJ,et al.Preparation and evaluation of the in vitro drug release properties and mucoadhesion of novel microspheres of hyaluronic acid and chitosan[J].J of Controlled Release,2000,66:281-292.
  • 7Denkbas EB,Seyyal M,Piskin E.Implantable 5-fluorouracil loaded chitosan scaffolds prepared by wet spinning[J].J of Membrane Science,2000,172:33-38.
  • 8Illum L,Jorgensed H,Bisgaard H,et al.Bioadhesive microspheres as a potential nasal drug delivery system[J].Int J Pharm,1987,39(3):189-195.
  • 9Sheu MT,Sokoloski TD.Entrapment of bioactive compounds within native albumin beads:Ⅲ.Evaluation of parameters affecting drug release[J].J Parenter Sci Technol,1986,40(6):259-266.
  • 10[3]Yamin W, Hitoshi S, Isao A, et al. Optimization of the Formulation Design of Chitosan Microspheres Containing Cisplatin[ J]. J Pharm Sci, 1996,85( 11 ): 1204 - 1210.

共引文献181

同被引文献61

引证文献6

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部